← Back to catalogue

Methotrexate Level 2

FDA UDI

Class I (US FDA UDI)

by Utak Laboratories, Inc.

Identity

Trade Name
Methotrexate Level 2 FDA UDI
Generic Name
Methotrexate therapeutic drug monitoring IVD, control FDA UDI
Device Name
Methotrexate Level 2 FDA UDI
Model / Reference
12104 FDA UDI
Description
Methotrexate Level 2 FDA UDI

Identifiers

Catalog Number
12104 FDA UDI
Primary DI / UDI-DI
B800121040 FDA UDI
FDA Product Code
LAS FDA UDI
GMDN Term
Methotrexate therapeutic drug monitoring IVD, control FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
862.3280 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Dimensions & Sizes

Size
Total Volume — 5 Milliliter FDA UDI

Category: Methotrexate therapeutic drug monitoring IVD, control

Methotrexate Level 2 by Utak Laboratories, Inc. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Methotrexate therapeutic drug monitoring IVD, control.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Utak Laboratories, Inc.

Sources (1)

  • FDA UDI 77ad766f-162e-46da-bc42-9298001f7097 37 fields · synced May 30, 2026